A 2024 analysis by the Medicaid and CHIP Payment and Access Commission (MACPAC) estimated that covering GLP-1 receptor agonists for all Medicaid-eligible adults with obesity would cost $13.6 billion annually across all states (MACPAC 2024)
References Bronleigh, M., Baumann, O., & Stapleton, P
Wellness From Every Angle We dont do one-dimensional plans
Venous Stasis: Increased blood viscosity from dehydration slows blood flow, especially in the leg veins, increasing the risk of deep vein thrombosis (DVT) due to venous stasis
Several studies showed evident association between type II diabetes and cancer, in particular in liver and pancreas, organs persistently exposed to high levels of endogenous insulin 117,118,119
Abstract Obesity is a major modifiable contributor to knee osteoarthritis (KOA), but excess adiposity has often been managed as a background risk factor rather than as a therapeutic target